Skip to main content
Top
Published in: Forensic Science, Medicine and Pathology 1/2024

Open Access 15-04-2023 | Suicide | Original Article

The analysis of ramipril/ramiprilat concentration in human serum with liquid chromatography-tandem mass spectrometry – interpretation of high concentrations for the purposes of forensic toxicology

Authors: Marek Dziadosz, Wolfgang Rosenberger, Michael Klintschar, Jörg Teske

Published in: Forensic Science, Medicine and Pathology | Issue 1/2024

Login to get access

Abstract

Ramipril is a popular angiotensin-converting enzyme inhibitor applied in the treatment of hypertension. Its therapeutic effect is oriented on the concentration of the active metabolite ramiprilat. The information about toxic drug levels is missing in the literature. Therefore, the aim of this work was an indication of possible toxic ranges based on the analysis of real samples with high ramiprilat concentrations. For these purposes, an appropriate analytical LC–MS/MS method was developed and validated according to forensic guidelines and applied in the routine. Most real samples targeted for ramipril/ramiprilat were associated with the typical therapeutic drug range of 1–40 ng/mL described in the literature. However, higher drug levels with ramiprilat concentrations above 100 ng/mL could also be observed infrequently in cases of driving under the influence of drugs or attempted suicides. To the best of the author’s knowledge, this is the first time antemortem ramipril and ramiprilat concentrations associated with driving under the influence of drugs and suicide attempts were discussed from a forensic point of view. The collected data enabled an indication of the ramiprilat toxic concentration range from about 600 ng/mL to at least 3500 ng/mL. The toxic concentration range discussed can be applied in the forensic practice as a reference for future cases.
Literature
1.
go back to reference Baselt RC. Disposition of toxic drugs and chemicals in man. 10th ed. Seal Beach, California: Biomedical Publications; 2014. Baselt RC. Disposition of toxic drugs and chemicals in man. 10th ed. Seal Beach, California: Biomedical Publications; 2014.
2.
go back to reference Mendes GD, Dantas Sanfelice AT, do Carmo Borges NC, Cavedal LE, Sverdloff C, Prado Galuppo M, Módolo JH, De Nucci G. Comparative bioavailability of two ramipril formulations after single-dose administration in healthy volunteers. Int J Clin Pharmacol Ther. 2006;44:93–8.CrossRefPubMed Mendes GD, Dantas Sanfelice AT, do Carmo Borges NC, Cavedal LE, Sverdloff C, Prado Galuppo M, Módolo JH, De Nucci G. Comparative bioavailability of two ramipril formulations after single-dose administration in healthy volunteers. Int J Clin Pharmacol Ther. 2006;44:93–8.CrossRefPubMed
3.
go back to reference Shionori H, Miyakawa T, Yasuda Ishikawa Y, Umemura S, Miyajima E, Kaneko Y. Pharmacokinetics of a single dose of ramipril in patients with renal dysfunction: comparison with essential hypertension. J Cardiovasc Pharmacol. 1987;10:S145–7.CrossRef Shionori H, Miyakawa T, Yasuda Ishikawa Y, Umemura S, Miyajima E, Kaneko Y. Pharmacokinetics of a single dose of ramipril in patients with renal dysfunction: comparison with essential hypertension. J Cardiovasc Pharmacol. 1987;10:S145–7.CrossRef
4.
go back to reference Meyer BH, Muller FO, Badian M, Eckert HG, Hajdú P, Irmisch R, Schmidt D. Pharmacokinetics of ramipril in the elderly. Am J Cardiol. 1987;59:33D–37D.CrossRefPubMed Meyer BH, Muller FO, Badian M, Eckert HG, Hajdú P, Irmisch R, Schmidt D. Pharmacokinetics of ramipril in the elderly. Am J Cardiol. 1987;59:33D–37D.CrossRefPubMed
5.
go back to reference Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.CrossRefPubMedPubMedCentral Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.CrossRefPubMedPubMedCentral
7.
go back to reference Wagner JA, Störk S, Kraus M, Langenfeld H. Reanimationspflichtigkeit und protrahierte Kardiodepression nach suizidaler Metoprolol/Ramipril-Intoxikation. Intensivmed. 2006;43:50–4.CrossRef Wagner JA, Störk S, Kraus M, Langenfeld H. Reanimationspflichtigkeit und protrahierte Kardiodepression nach suizidaler Metoprolol/Ramipril-Intoxikation. Intensivmed. 2006;43:50–4.CrossRef
8.
go back to reference Theofel N, Vejmelka E, Roscher S, Tsokos M, Scholtis S. Wieviel Ramiprilat kann in Leichenblut und Liquor nachgewiesen werden? Toxichem Krimtech. 2019;86:181–7. Theofel N, Vejmelka E, Roscher S, Tsokos M, Scholtis S. Wieviel Ramiprilat kann in Leichenblut und Liquor nachgewiesen werden? Toxichem Krimtech. 2019;86:181–7.
9.
go back to reference Palakurthi AK, Dongala T, Yadlapalli SSR. Estimation of ramipril and telmisartan in human plasma by LC-MS/MS: application in pharmacokinetic study. Sep Sci plus. 2020;3:191–9.CrossRef Palakurthi AK, Dongala T, Yadlapalli SSR. Estimation of ramipril and telmisartan in human plasma by LC-MS/MS: application in pharmacokinetic study. Sep Sci plus. 2020;3:191–9.CrossRef
10.
go back to reference Saha A, Vats P, Gurule SJ, Khuroo A. Sensitive LC-MS/MS method for the determination of ramipril in human plasma: application to a bioequivalence study in Indian volunteers. J Pharm Innov. 2017;12:90–104.CrossRef Saha A, Vats P, Gurule SJ, Khuroo A. Sensitive LC-MS/MS method for the determination of ramipril in human plasma: application to a bioequivalence study in Indian volunteers. J Pharm Innov. 2017;12:90–104.CrossRef
11.
go back to reference Szpot P, Buszewicz G. Determination of ramipril in human plasma and its fragmentation by UPLC-Q-TOF-MS with positive electrospray ionization. Acta Pharm. 2015;65:159–69.CrossRefPubMed Szpot P, Buszewicz G. Determination of ramipril in human plasma and its fragmentation by UPLC-Q-TOF-MS with positive electrospray ionization. Acta Pharm. 2015;65:159–69.CrossRefPubMed
12.
go back to reference Pilli NR, Inamadugu JK, Mullangi R, Karra VK, Vaidya JR, Rao JVLNS. Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study. Biomed Chromatogr. 2011;25:439–49.CrossRefPubMed Pilli NR, Inamadugu JK, Mullangi R, Karra VK, Vaidya JR, Rao JVLNS. Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study. Biomed Chromatogr. 2011;25:439–49.CrossRefPubMed
13.
go back to reference Peters FT, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff F. Anhang B zur richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech. 2009;76:185–208. Peters FT, Hartung M, Herbold M, Schmitt G, Daldrup T, Mußhoff F. Anhang B zur richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen. Anforderungen an die Validierung von Analysenmethoden. Toxichem Krimtech. 2009;76:185–208.
14.
go back to reference Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75:3019–30.CrossRefPubMed Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem. 2003;75:3019–30.CrossRefPubMed
15.
go back to reference Yuan B, Wang X, Zhang F, Jia J, Tang F. Simultaneous determination of ramipril and its active metabolite ramiprilat in human plasma by LC-MS-MS. Chromatographia. 2008;68:533–9.CrossRef Yuan B, Wang X, Zhang F, Jia J, Tang F. Simultaneous determination of ramipril and its active metabolite ramiprilat in human plasma by LC-MS-MS. Chromatographia. 2008;68:533–9.CrossRef
16.
go back to reference Lu XY, Shen-Tu JZ, Liu J. High-performance liquid chromatography-mass spectrometric analysis of Ramipril and its active metabolite ramiprilat in human serum: application to a pharmacokinetic study in the Chinese volunteers. J Pharm Biomed Anal. 2006;40:478–83.CrossRefPubMed Lu XY, Shen-Tu JZ, Liu J. High-performance liquid chromatography-mass spectrometric analysis of Ramipril and its active metabolite ramiprilat in human serum: application to a pharmacokinetic study in the Chinese volunteers. J Pharm Biomed Anal. 2006;40:478–83.CrossRefPubMed
17.
go back to reference Heintz B, Verho M, Brockmeier D, Lückel G, Maigatter S, Sieberth HG, Rangoonwala B, Bender N. Multi-dose pharmacokinetics of ramipril in patients with chronic congestive heart failure. J Cardiovas Pharmacol. 1993;22:S36–42.CrossRef Heintz B, Verho M, Brockmeier D, Lückel G, Maigatter S, Sieberth HG, Rangoonwala B, Bender N. Multi-dose pharmacokinetics of ramipril in patients with chronic congestive heart failure. J Cardiovas Pharmacol. 1993;22:S36–42.CrossRef
18.
go back to reference Lucas C, Christie GA, Waring WS. Rapid onset of haemodynamic effects after angiotensin converting enzyme-inhibitor overdose: implications for initial patient triage. Emerg Med J. 2006;23:854–7.CrossRefPubMedPubMedCentral Lucas C, Christie GA, Waring WS. Rapid onset of haemodynamic effects after angiotensin converting enzyme-inhibitor overdose: implications for initial patient triage. Emerg Med J. 2006;23:854–7.CrossRefPubMedPubMedCentral
19.
go back to reference Frampton JE, Peters DH. Ramipril: An update review of its therapeutic use in essential hypertension and heart failure. Drugs. 1995;49:440–66.CrossRefPubMed Frampton JE, Peters DH. Ramipril: An update review of its therapeutic use in essential hypertension and heart failure. Drugs. 1995;49:440–66.CrossRefPubMed
20.
go back to reference Schunkert H, Kindler J, Gassmann M, Lahn W, Irmisch R, Debusmann ER, Ocón-Pujadas J, Sieberth HG. Steady-state kinetics of ramipril in renal failure. J Cardiovasc Pharmacol. 1989;13:S52–4.CrossRefPubMed Schunkert H, Kindler J, Gassmann M, Lahn W, Irmisch R, Debusmann ER, Ocón-Pujadas J, Sieberth HG. Steady-state kinetics of ramipril in renal failure. J Cardiovasc Pharmacol. 1989;13:S52–4.CrossRefPubMed
21.
go back to reference Gilchrist WJ, Beard K, Manhem P, Thomas EM, Robertson JIS, Ball SG. Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients. Am J Cardiol. 1987;59:D28–32.CrossRef Gilchrist WJ, Beard K, Manhem P, Thomas EM, Robertson JIS, Ball SG. Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients. Am J Cardiol. 1987;59:D28–32.CrossRef
22.
go back to reference Meyer BH, Müller FO, Badian M, Eckert HG, Hajdú P, Irmisch R, Schmidt D. Pharmacokinetics of ramipril in the elderly. Am J Cardiol. 1987;59:D33–7.CrossRef Meyer BH, Müller FO, Badian M, Eckert HG, Hajdú P, Irmisch R, Schmidt D. Pharmacokinetics of ramipril in the elderly. Am J Cardiol. 1987;59:D33–7.CrossRef
Metadata
Title
The analysis of ramipril/ramiprilat concentration in human serum with liquid chromatography-tandem mass spectrometry – interpretation of high concentrations for the purposes of forensic toxicology
Authors
Marek Dziadosz
Wolfgang Rosenberger
Michael Klintschar
Jörg Teske
Publication date
15-04-2023
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 1/2024
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-023-00621-6

Other articles of this Issue 1/2024

Forensic Science, Medicine and Pathology 1/2024 Go to the issue